How to Manage (Treat) Immediate-type Adverse Reactions to GBCA

Henrik S Thomsen

doi:10.1097/RMR.0000000000000107

How to Manage (Treat) Immediate-type Adverse Reactions to GBCA

Henrik S Thomsen

Afdeling for Røntgen og Skanning HGH

6 Citationer (Scopus)

Abstract

Acute nonrenal adverse reactions to gadolinium-based contrast agents are infrequent and occur often unexpectedly. Most reactions are self-limiting and do not require treatment. The remaining adverse reactions are either moderate or severe and they require medical treatment. Prompt and effective treatment is very important and requires knowledge, training, and preparation.

Originalsprog	Engelsk
Tidsskrift	Journal of Magnetic Resonance Imaging
Vol/bind	25
Udgave nummer	6
Sider (fra-til)	269-274
Antal sider	6
ISSN	1053-1807
DOI	https://doi.org/10.1097/RMR.0000000000000107
Status	Udgivet - dec. 2016

Adgang til dokumentet

10.1097/RMR.0000000000000107

Citationsformater

@article{5b9c589b81bd46278e41790c58ff45fa,

title = "How to Manage (Treat) Immediate-type Adverse Reactions to GBCA",

abstract = "Acute nonrenal adverse reactions to gadolinium-based contrast agents are infrequent and occur often unexpectedly. Most reactions are self-limiting and do not require treatment. The remaining adverse reactions are either moderate or severe and they require medical treatment. Prompt and effective treatment is very important and requires knowledge, training, and preparation.",

keywords = "Chelating Agents, Contrast Media, Drug Hypersensitivity, Evidence-Based Medicine, Gadolinium, Humans, Hypersensitivity, Immediate, Magnetic Resonance Imaging, Treatment Outcome, Journal Article, Review",

author = "Thomsen, {Henrik S}",

year = "2016",

month = dec,

doi = "10.1097/RMR.0000000000000107",

language = "English",

volume = "25",

pages = "269--274",

journal = "Journal of Magnetic Resonance Imaging",

issn = "1053-1807",

publisher = "John Wiley and Sons Inc.",

number = "6",

}

TY - JOUR

T1 - How to Manage (Treat) Immediate-type Adverse Reactions to GBCA

AU - Thomsen, Henrik S

PY - 2016/12

Y1 - 2016/12

N2 - Acute nonrenal adverse reactions to gadolinium-based contrast agents are infrequent and occur often unexpectedly. Most reactions are self-limiting and do not require treatment. The remaining adverse reactions are either moderate or severe and they require medical treatment. Prompt and effective treatment is very important and requires knowledge, training, and preparation.

AB - Acute nonrenal adverse reactions to gadolinium-based contrast agents are infrequent and occur often unexpectedly. Most reactions are self-limiting and do not require treatment. The remaining adverse reactions are either moderate or severe and they require medical treatment. Prompt and effective treatment is very important and requires knowledge, training, and preparation.

KW - Chelating Agents

KW - Contrast Media

KW - Drug Hypersensitivity

KW - Evidence-Based Medicine

KW - Gadolinium

KW - Humans

KW - Hypersensitivity, Immediate

KW - Magnetic Resonance Imaging

KW - Treatment Outcome

KW - Journal Article

KW - Review

U2 - 10.1097/RMR.0000000000000107

DO - 10.1097/RMR.0000000000000107

M3 - Review

C2 - 27849654

SN - 1053-1807

VL - 25

SP - 269

EP - 274

JO - Journal of Magnetic Resonance Imaging

JF - Journal of Magnetic Resonance Imaging

IS - 6

ER -

How to Manage (Treat) Immediate-type Adverse Reactions to GBCA

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater